Beida pharmaceutical: clinical trial of batirizumab injection in the treatment of cervical cancer approved

Survival Rules for Turbulent Times: A Compilation of the 20 Most Unmissable Core Insights from the 2026 Tsinghua PBCSF Forum

A dialogue between Zhu Min, former Deputy Governor of the People's Bank of China and former Vice Managing Director of the International Monetary Fund; Michael Spence, 2001 Nobel Prize winner in Economics and Philip H. Knight Professor Emeritus of Management at Stanford Graduate School of Business; and Masaaki Shirakawa, former Governor of the Bank of Japan, at the 2026 Tsinghua PBCSF Global Finance Forum.

SHEIN Launches Hong Kong IPO, Targeting Up to US$1.76 Billion

SHEIN（希音）launched its Hong Kong initial public offering on August 24, offering about 280 million Class B shares at HK$47.60 to HK$49.50 each. At the top of that range, the global offering could raise up to HK$13.86 billion (US$1.76 billion) before expenses, placing the fast-fashion retailer among Hong Kong’s largest planned listings of 2026.

Kanghong’s Conbercept Receives Marketing Authorization in Guyana

Kanghong Pharmaceutical (康弘药业) said its subsidiary Kanghong Bioscience had received a drug registration certificate from Guyana’s Food and Drug Department for conbercept ophthalmic injection, marketed under the brand name Lumitin (朗沐).

SHEIN Reportedly Targets US$26–27 Billion Valuation in Hong Kong IPO

SHEIN (希音), the China-founded global fashion and lifestyle retailer, is reportedly seeking a valuation of US$26 billion to US$27 billion in a planned Hong Kong initial public offering, a sharp reduction from the US$98.2 billion private-market valuation disclosed for its 2022 fundraising round.

TikTok Shop’s US Online-Spending Share Reaches 2%, Consumer Edge Data Show

TikTok Shop accounted for about 2% of US online retail spending in July, exceeding the estimated online spending captured by Target, Costco and Home Depot, according to Consumer Edge transaction data cited by Chinese e-commerce outlet Ebrun.